Theaim of this study, which focused on distant disease-free survival (DDFS) andoverall survival (OS), was to evaluate differences in Ki67 expression andoutcomes among patients with ER+/HER2– breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.